ARISE - Aggressive Reduction of Inflammation Stops Events

Status unconfirmed · Phase 3

Conditions studied: Atherosclerosis, Coronary Artery Disease, Myocardial Infarction, Unstable Angina

In brief

To assess the safety and efficacy of AGI-1067, as compared to placebo, in the treatment of vascular inflammation and atherosclerosis by assessing the reduction in cardiovascular events.

Key facts

Study ID
NCT00066898
Run by
AtheroGenics
People needed
6000
Starts
2003-06-01
Expected to finish
2006-12-01
Last updated by the study team
2006-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.